课题基金 / 基金详情

Novel Biocatalysts for Improved Routes to an Active Pharmaceutical Ingredient

Novel Biocatalysts for Improved Routes to an Active Pharmaceutical Ingredient
用于改进活性药物成分路线的新型生物催化剂
批准号:
BB/N010736/1
负责人:
Nicholas Turner
金额:
$11.94万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2016
资助国家:
英国
项目状态:
已结题
起止时间:
2016 至 --

项目摘要

项目成果

Nicholas Turner的其他基金

相似基金

相关文献

中文摘要
翻译
使用酶催化反应是现代有机化学中使用的成熟技术,因为使用生物催化剂可以将独特和精致的立体化学和区域化学安装到合成路线中。该项目将探索两种酶的开发,这两种酶在活性药物成分的合成中催化重要的键形成反应,以及它们作为工业生物催化剂的适用性。
英文摘要
The use of enzymes to catalyse reactions is a well established technique used in modern organic chemistry as the use of biological catalysts can install unique and exquisite stereochemistry and regiochemistry into a synthetic route. This project will explore the development of two enzymes that catalyse important bond forming reactions in the synthesis of an Active Pharmaceutical Ingredient and their suitability for use as industrial biocatalysts.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
New Synthetic Chaperones to Enhance Protein Activity
  • 批准号:
    EP/V056085/2
  • 项目类别:
    Fellowship
  • 资助金额:
    $136.79万
  • 财政年份:
    2023
  • 负责人:
    Nicholas Turner
  • 依托单位:
Directed Molecular Recognition through Next-Generation Hybrid Molecular Imprinting
  • 批准号:
    EP/V046594/2
  • 项目类别:
    Research Grant
  • 资助金额:
    $17.83万
  • 财政年份:
    2023
  • 负责人:
    Nicholas Turner
  • 依托单位:
New Synthetic Chaperones to Enhance Protein Activity
  • 批准号:
    EP/V056085/1
  • 项目类别:
    Fellowship
  • 资助金额:
    $165.83万
  • 财政年份:
    2022
  • 负责人:
    Nicholas Turner
  • 依托单位:
Biocatalytic Manufacturing of Nucleic Acid Therapeutics
  • 批准号:
    MR/W029324/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $817.8万
  • 财政年份:
    2022
  • 负责人:
    Nicholas Turner
  • 依托单位:
海外基金